Figure 5 - available via license: Creative Commons Attribution-NonCommercial 3.0 Unported
Content may be subject to copyright.
Download
View publication
H&E staining of heart, liver, spleen, lung, and kidney; ×200. Abbreviations: DOX, doxorubicin; H&E, hematoxylin and eosin; MDR, multidrug resistance; MSNP, mesoporous silica nanoparticles; PEI, polymerpolyethylenimine.

H&E staining of heart, liver, spleen, lung, and kidney; ×200. Abbreviations: DOX, doxorubicin; H&E, hematoxylin and eosin; MDR, multidrug resistance; MSNP, mesoporous silica nanoparticles; PEI, polymerpolyethylenimine.

Source publication
Figure 5 H&E staining of heart, liver, spleen, lung, and kidney; ×200....
Codelivery of Doxorubicin and MDR1-siRNA by Mesoporous Silica Nanoparticles-Polymerpolyethylenimine to Improve Oral Squamous Carcinoma Treatment [Corrigendum]
Article
Full-text available
  • Dec 2021
Wang D, Xu X, Zhang K, et al. Int J Nanomedicine. 2018;13:187–198. The authors have advised due to an error at the time of figure assembly, Figure 5 on page 195 is incorrect. The correct Figure 5 is shown in Download Article. The authors apologize for this error and advise it does not affect the results of the paper. Read the original article
Cite
Download full-text